Mitralign Inc.
This article was originally published in Start Up
Executive Summary
Mitralign Inc.'s percutaneous approach to mitral valve repair mimics surgical annuloplasty, the current gold standard treatment for reducing the dilated annulus to a functional size. The company is targeting patients who have both congestive heart failure and mitral valve regurgitation.